Themis Medicare Ltd shares pledged by CTL Trusteeship covering 27.49% stake

What Themis Medicare announced

On 2 July 2026, Themis Medicare Ltd (BSE: 530199) filed a disclosure under Regulation 29(1) of the SEBI Substantial Acquisition of Shares & Takeovers (SAST) Regulations, 2011. The filing, submitted by CTL Trusteeship Limited in its capacity as debenture trustee, informs the market that a pledge has been created over 2,53,17,620 equity shares of Themis Medicare. These shares represent 27.49 % of the company’s issued and paid‑up share capital. The pledge was effected on 29 June 2026 and is held in favour of the debenture trustee for the benefit of debenture holders.

Details of the pledge and parties involved

The equity shares subject to the pledge are owned by Vividhmargi Trust. The legal owners of the trust are three individuals – Mr Dinesh Shantilal Patel, Mrs Jayshree Dinesh Patel and Dr Sachin Dinesh Patel – who appear as trustees in the company’s records and in the depository. Under the Debenture Trust Deed, CTL Trusteeship Limited, acting as the debenture trustee, created a security interest over these shares. The pledge does not involve a transfer of ownership; rather, it restricts the ability of the trust to sell or otherwise dispose of the shares without the consent of the debenture trustee. The filing does not disclose any conversion rights, redemption timeline, or other terms beyond the creation of the encumbrance.

Regulatory framework and filing specifics

The disclosure is made pursuant to Regulation 29(1) of the SEBI (SAST) Regulations, 2011, which requires any party acquiring, or creating an encumbrance over, a material shareholding to inform the stock exchanges. The filing references Regulation 10(6) of the same rules, indicating that the pledge is treated as a substantial acquisition for reporting purposes. The filing provides the following quantitative details:

• Total equity share capital of Themis Medicare before and after the pledge: INR 9,21,00,120, comprising 9,21,00,120 fully paid‑up shares of ₹1 each.
• Number of pledged shares: 2,53,17,620.
• Percentage of total share capital represented by the pledged shares: 27.49 %.
• Date of creation of the encumbrance: 29 June 2026.
• Date of filing: 2 July 2026. The filing does not indicate any change in the total voting capital, nor does it mention any alteration to the rights of existing shareholders.

Key facts at a glance

Why this matters for investors

The creation of a pledge over more than a quarter of Themis Medicare’s equity introduces a security interest that could affect the free‑float of the shares. While the pledge does not transfer ownership, it restricts the ability of the Vividhmargi Trust to sell the pledged shares without the debenture trustee’s consent. This could limit the supply of shares in the market and may have implications for future share‑based transactions, such as rights issues or secondary offerings. However, the filing does not indicate any immediate dilution, change in voting rights, or impact on dividend entitlement for existing shareholders. Investors should monitor any subsequent disclosures that might detail the terms of the debenture, including conversion rights or redemption triggers, as these could affect the ultimate disposition of the pledged shares.

Conclusion

The filing dated 2 July 2026 confirms that CTL Trusteeship Limited, as debenture trustee, has pledged 2.53 crore shares of Themis Medicare Ltd, representing 27.49 % of the company’s equity, on behalf of Vividhmargi Trust. The pledge creates an encumbrance but does not alter the share count or voting structure at present. Further information may be required to understand any future actions by the debenture trustee that could affect the pledged shares.